OSCROscar Health, Inc.
Is the price fair?
Cheap vs its sector. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Sector median 22.6× across 130 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What OSCR's price assumes
Oscar Health, Inc. trades at 25.6× earnings against 25.0× for the median Healthcare Plans name, more expensive than its own group.
Trailing P/E · Healthcare Plans median 25.0 · 1.02× the median: the market pays up for this one
- Price / sales
- 0.56
Price / sales · today's price, trailing year to Jun 30, 2026
- Price / book
- 4.21
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 0.03
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 4.21
- EV / EBITtoday's price, trailing year to Jun 30, 2026
- 0.83
- EV / salestoday's price, trailing year to Jun 30, 2026
- 0.03
- Healthcare median P/E509 names
- 26.2
- Healthcare Plans median P/E11 names
- 25.0
- Market capitalisation
- $8.64B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.